Current state of frontline immunotherapy options in the treatment of NSCLC - report from ASCO2021

from Medical Digest & Congress Report · host Medical Congress News

Prof.  Federico Cappuzzo, Director of Medical Oncology in National Cancer Institute from Italy summarize the current state of frontline immunotherapy options in the treatment of NSCLC both in early stage and in metastatic advanced disease. Video: https://congressreport.eu/scientific-contents/interview:current-state-frontline-immunotherapy-options-treatment-nsclc

Episode metadata supplied by the publisher feed · Published Jul 19, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Current state of frontline immunotherapy options in the treatment of NSCLC - report from ASCO2021

0:00 8:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 8 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on July 19, 2021.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!